Eyal Desheh，他曾担任我们公司的外部董事。他的任命于2012年12月1日Stratasys公司和Objet公司完成合并时生效，并于2013年2月被我们的股东批准。他目前担任Teva Pharmaceutical Industries公司（NYSE:TEVA,全球制药和制药公司）的首席财务官（从2008年7月到2013年10月），以及集团执行副总裁（2012年以来)。从2013年10月到2014年2月，他担任Teva公司的总裁兼首席执行官。从2000年到2008年，他曾担任Check Point Software Technologies公司（NASDAQ:CHKP，网络安全解决方案的全球领先供应商）的执行副总裁和首席财务官。从1996年到2000年，他曾担任Scitex Corporation(NASDAQ & TASE:SCIX)的首席财务官。从1989年到1996年，他曾担任Teva Pharmaceuticals公司的财务副总监。他持有the Hebrew University in Jerusalem的经济学学士学位，以及财务工商管理硕士学位。

Eyal Desheh is a non-executive director and was a member of our supervisory board from November 2012 until the supervisory board was disbanded on July 10 2014 when he became a member of our current board of directors. Mr. Desheh served as Deputy Chief Financial Officer of Teva Pharmaceutical Industries NYSE:TEVA ( Teva ), an international pharmaceutical company that produces generic and specialty medicines, from 1989 to 1996 as Teva s Chief Financial Officer from 2008 to 2012 as Teva s Group Executive Vice President from 2012 to 2013 and as Teva s acting President and CEO from October 2013 to February 2014. In February 2014 Mr. Desheh resumed his role as Teva s Chief Financial Officer. Mr. Desheh also served as Chief Financial Officer of Scitex Ltd., a printing equipment manufacturer, from 1996 to 2000 and as Executive Vice President and Chief Financial Officer of Check Point Software Technologies Ltd., an international provider of information technology security products, between 2000 and 2008. Mr. Desheh received a B.A. in Economics in 1978 and an M.B.A. in Finance in 1981 both from the Hebrew University. Eyal Desheh，他曾担任我们公司的外部董事。他的任命于2012年12月1日Stratasys公司和Objet公司完成合并时生效，并于2013年2月被我们的股东批准。他目前担任Teva Pharmaceutical Industries公司（NYSE:TEVA,全球制药和制药公司）的首席财务官（从2008年7月到2013年10月），以及集团执行副总裁（2012年以来)。从2013年10月到2014年2月，他担任Teva公司的总裁兼首席执行官。从2000年到2008年，他曾担任Check Point Software Technologies公司（NASDAQ:CHKP，网络安全解决方案的全球领先供应商）的执行副总裁和首席财务官。从1996年到2000年，他曾担任Scitex Corporation(NASDAQ & TASE:SCIX)的首席财务官。从1989年到1996年，他曾担任Teva Pharmaceuticals公司的财务副总监。他持有the Hebrew University in Jerusalem的经济学学士学位，以及财务工商管理硕士学位。Eyal Desheh is a non-executive director and was a member of our supervisory board from November 2012 until the supervisory board was disbanded on July 10 2014 when he became a member of our current board of directors. Mr. Desheh served as Deputy Chief Financial Officer of Teva Pharmaceutical Industries NYSE:TEVA ( Teva ), an international pharmaceutical company that produces generic and specialty medicines, from 1989 to 1996 as Teva s Chief Financial Officer from 2008 to 2012 as Teva s Group Executive Vice President from 2012 to 2013 and as Teva s acting President and CEO from October 2013 to February 2014. In February 2014 Mr. Desheh resumed his role as Teva s Chief Financial Officer. Mr. Desheh also served as Chief Financial Officer of Scitex Ltd., a printing equipment manufacturer, from 1996 to 2000 and as Executive Vice President and Chief Financial Officer of Check Point Software Technologies Ltd., an international provider of information technology security products, between 2000 and 2008. Mr. Desheh received a B.A. in Economics in 1978 and an M.B.A. in Finance in 1981 both from the Hebrew University.

>>> 更多资讯详情请访问蚂蚁淘商城